We added the following clinical trials for HR-positive, HER2-positive, and other subtypes of metastatic (stage IV) breast cancer to Metastatic Trial Search last month.
Stage IV HER2-Positive Trials
Stage IV HR-Positive Trials
- Enobosarm for Androgen Receptor Positive (AR+), ER+, HER2- Metastatic Breast Cancer
- Camizestrant with Targeted Therapy for Advanced HR+, HER2- Breast Cancer with an ESR1 Mutation
Stage IV Triple Negative Breast Cancer
- Sacituzumab Govitecan-Hziy with Chemo and Immunotherapy for Metastatic Triple-Negative Breast Cancer
- Magrolimab with Chemotherapy for Advanced Triple-Negative Breast Cancer
Other Stage IV Trials
- CX-5461 for Advanced Breast Cancer with a BRCA2 or PALB2 Mutation
- Niraparib for Advanced Breast Cancer with a PALB2 Mutation
- Deferoxamine For Leptomeningeal Metastasis
Last Modified on March 4, 2022
